Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Markin

Showing results (231-240 of 245) with videos related to

Pageof 25
Sort By:
Biomeditsinskaia Khimiia|November 3, 2021
[PCR analysis of the expression of chromosome 18 genes in human liver tissue: interindividual variability]O S Timoshenko, S A Khmeleva, E V Poverennaya, et al.
Angiologiia I Sosudistaia Khirurgiia = Angiology and Vascular Surgery|March 10, 2026
[Intraarterial intrathrombus thrombolysis with non-immunogenic staphylokinase vs surgery in patients with acute limb ischemia: protocol of a multicenter, open-label, randomized clinical trial FORAT]I I Zatevakhin, A V Chupin, A A Karpenko, et al.
Pediatric Transplantation|March 19, 1999
Correlation of mucosal disaccharidase activities with histology in evaluation of rejection following intestinal transplantationS S Kaufman, J L Wisecarver, E I Ruby, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2024
Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPEAlexander I Kirienko, Stanislav G Leontyev, Sergey N Tereschenko, et al.
Scientific Reports|February 1, 2024
A novel preliminary metabolomic panel for IHD diagnostics and pathogenesisS S Markin, E A Ponomarenko, Yu A Romashova, et al.
Scientific Reports|October 11, 2024
Targeted metabolomic profiling of acute ST-segment elevation myocardial infarctionSergey S Markin, E A Ponomarenko, Yu A Romashova, et al.
Biomeditsinskaia Khimiia|November 10, 2025
Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trialV V Kukharchuk, E A Ponomarenko, A V Lisitsa, et al.
Hepatology (Baltimore, Md.)|August 26, 1999
The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosisB Combes, R S Markin, D E Wheeler, et al.
Hepatology (Baltimore, Md.)|October 11, 2008
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assayMarlyn J Mayo, Julie Parkes, Beverley Adams-Huet, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosisBurton Combes, Scott S Emerson, Nancy L Flye, et al.
Pageof 25

Showing results (231-240 of 245) with videos related to

Sort By:
Pageof 25
Biomeditsinskaia Khimiia|November 3, 2021
[PCR analysis of the expression of chromosome 18 genes in human liver tissue: interindividual variability]O S Timoshenko, S A Khmeleva, E V Poverennaya, et al.
Angiologiia I Sosudistaia Khirurgiia = Angiology and Vascular Surgery|March 10, 2026
[Intraarterial intrathrombus thrombolysis with non-immunogenic staphylokinase vs surgery in patients with acute limb ischemia: protocol of a multicenter, open-label, randomized clinical trial FORAT]I I Zatevakhin, A V Chupin, A A Karpenko, et al.
Pediatric Transplantation|March 19, 1999
Correlation of mucosal disaccharidase activities with histology in evaluation of rejection following intestinal transplantationS S Kaufman, J L Wisecarver, E I Ruby, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2024
Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPEAlexander I Kirienko, Stanislav G Leontyev, Sergey N Tereschenko, et al.
Scientific Reports|February 1, 2024
A novel preliminary metabolomic panel for IHD diagnostics and pathogenesisS S Markin, E A Ponomarenko, Yu A Romashova, et al.
Scientific Reports|October 11, 2024
Targeted metabolomic profiling of acute ST-segment elevation myocardial infarctionSergey S Markin, E A Ponomarenko, Yu A Romashova, et al.
Biomeditsinskaia Khimiia|November 10, 2025
Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trialV V Kukharchuk, E A Ponomarenko, A V Lisitsa, et al.
Hepatology (Baltimore, Md.)|August 26, 1999
The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosisB Combes, R S Markin, D E Wheeler, et al.
Hepatology (Baltimore, Md.)|October 11, 2008
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assayMarlyn J Mayo, Julie Parkes, Beverley Adams-Huet, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosisBurton Combes, Scott S Emerson, Nancy L Flye, et al.
Pageof 25